These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35654461)

  • 1. Protocol and clinical characteristics of patients under 'at-home care' for COVID-19 in South Korea: a retrospective cohort study.
    Park JJ; Seo YB; Lee J; Na SH; Choi YK
    BMJ Open; 2022 Jun; 12(6):e061765. PubMed ID: 35654461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and Readmission Rates Among Patients With COVID-19 After Discharge From Acute Care Setting With Supplemental Oxygen.
    Banerjee J; Canamar CP; Voyageur C; Tangpraphaphorn S; Lemus A; Coffey C; Wald-Dickler N; Holtom P; Shoenberger J; Bowdish M; Yee HF; Spellberg B
    JAMA Netw Open; 2021 Apr; 4(4):e213990. PubMed ID: 33792728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Development and Operation of a Home Management System during the COVID-19 Pandemic: Experience of the Local Government Gyeonggi-do in Korea.
    Lee Y; Han JO; Lee H; Lim S
    J Korean Med Sci; 2021 May; 36(19):e134. PubMed ID: 34002552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Workload of Healthcare Workers During the COVID-19 Outbreak in Korea: A Nationwide Survey.
    Cheong HS; Kwon KT; Hwang S; Kim SW; Chang HH; Park SY; Kim B; Lee S; Park J; Heo ST; Oh WS; Kim Y; Park KH; Kang CK; Oh N; Lim SJ; Yun S; Son JW
    J Korean Med Sci; 2022 Feb; 37(6):e49. PubMed ID: 35166085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial.
    Klarskov CK; Lindegaard B; Pedersen-Bjergaard U; Kristensen PL
    Trials; 2020 Nov; 21(1):968. PubMed ID: 33239100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Critical COVID-19 Cases Among Children in Korea.
    Lee H; Choi S; Park JY; Jo DS; Choi UY; Lee H; Jung YT; Chung IH; Choe YJ; Kim JY; Park YJ; Choi EH
    J Korean Med Sci; 2022 Jan; 37(1):e13. PubMed ID: 34981683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.
    Shi HJ; Yang J; Eom JS; Ko JH; Peck KR; Kim UJ; Jung SI; Kim S; Seok H; Hyun M; Kim HA; Kim B; Joo EJ; Cheong HS; Jun CH; Wi YM; Kim J; Kym S; Lim S; Park Y
    J Korean Med Sci; 2023 Jul; 38(28):e217. PubMed ID: 37463688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring and Management of Home-Quarantined Patients With COVID-19 Using a WeChat-Based Telemedicine System: Retrospective Cohort Study.
    Xu H; Huang S; Qiu C; Liu S; Deng J; Jiao B; Tan X; Ai L; Xiao Y; Belliato M; Yan L
    J Med Internet Res; 2020 Jul; 22(7):e19514. PubMed ID: 32568727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Was size of healthcare institution a factor affecting changes in healthcare utilisation during the COVID-19 pandemic in Korea? A retrospective study design analysing national healthcare big data.
    Park YT; Lane C; Lee HJ; Lee J
    BMJ Open; 2022 Dec; 12(12):e064537. PubMed ID: 36600350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Assessment of Importation and Local Transmission of COVID-19 in South Korea: Statistical Modeling Approach.
    Lee H; Kim Y; Kim E; Lee S
    JMIR Public Health Surveill; 2021 Jun; 7(6):e26784. PubMed ID: 33819165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the COVID-19 pandemic on unmet healthcare needs in Seoul, South Korea: a cross-sectional study.
    Kim J; You M; Shon C
    BMJ Open; 2021 Aug; 11(8):e045845. PubMed ID: 34446482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of daily living in nursing home and home care settings: a retrospective 1-year cohort study.
    Lee TW; Cho E; Yim ES; Lee HS; Ko YK; Kim BN; Kim S
    J Am Med Dir Assoc; 2015 Feb; 16(2):114-9. PubMed ID: 25244958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.